Print

John W. Hazard Jr

John W HazardJohn W. Hazard Jr.
Partner
Webster, Chamberlain & Bean, LLP.
Washington, DC

Mr. Hazard has been a partner with the firm since 1988 and is admitted to practice in Washington, D.C. and Virginia.

His practice includes all areas of nonprofit corporate and tax law including antitrust, tax, contracts, human resource matters, mergers, compensation, and intellectual property. Mr. Hazard has worked with and represents associations and companies of all types including publicly traded and private corporations, trade and professional groups, foundations, charities, and sports groups. Mr. Hazard has litigated numerous trademark infringement matters both in the U.S. and abroad, as well as domain name disputes and general corporate matters. He has been very successful in stopping trademark infringement for many of his clients and regularly assists in developing intellectual property policing and registration programs on a world-wide basis.

Mr. Hazard has lectured extensively in the areas of corporate governance, mergers, trademark and copyright infringement, and is the author of a treatise on copyright law, Copyright Law In Business and Practice (Thomson West), which is updated twice annually. He is the general counsel for the American Payroll Association, the Institute of Internal Auditors, the Messenger Courier Association of the Americas, the Mulch & Soil Council, the American Music Therapy Association, United Service Association for Health Care and many other associations and for-profit companies.

ObamaCare 2013: Immediate and Future Developments

By John W. Hazard, Jr.

The Affordable Care Act marches on and brings with it new taxes, regulations and mandates in 2013 and 2014. The law will not reach full implementation for several years, but its momentum for change continues to increase. As of January, 2013, we have a host of new taxes and a warning that we need to prepare for 2014. John Hazard, of Webster, Chamberlain & Bean, will present a brief summary/update of the law in a talk on April 5th at 10:15 a.m. Developments to be considered: Capital gains tax increases; hike in Medicare Payroll Tax; increase in “floor” of AGI [to 10%] for deduction of medical expenses on personal income tax return; elimination of tax deduction for employer-provided retirement RX drug coverage in coordination with Medicare Part D. Also, as of January 2013, ObamaCare imposes a $2,500 cap on Flexible Spending Account (FSA) contributions. The cap is to be indexed to inflation every year after 2013. The U.S. Senate voted 79-20 last week to repeal a 2.3 percent excise tax on medical devices. The so-called “medical device tax” became effective in 2013 and may not survive since the Senate vote made clear a surprising bi-partisan support. The Medical Device Manufacturers Association claims the tax has already cost affected manufacturers almost $400 million. The lopsided vote was, however, only for an amendment to the Senate budget, a rarely approved item these days, so more formal legislation will be needed to eliminate the tax.

There will be a hand-out at the presentation and time for Q & A.